RHIZEN-PHARMACEUTICALS
2.12.2020 10:35:17 CET | Business Wire | Press release
Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company, today announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to study its oral DHODH inhibitor for SARS-CoV-2 infection. The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020. The company also announces positive feedback from the FDA during its pre-IND discussion on its plans to follow-up this study with a multiple-ascending dose study in Covid-19 patients.
Dihydroorotate dehydrogenase (DHOHD) is a key enzyme involved in pyrimidine biosynthesis in the cell. RP7214 is potentially a best-in-class selective DHODH inhibitor that has shown potent inhibition of Covid-19 viral replication. RP7214 has also been studied extensively across multiple inflammation models where it has demonstrated excellent anti-inflammatory activity. Further, the IND-enabling preclinical studies have shown RP7214 to be orally available, safe and tolerable with predictable dose-linear pharmacokinetics. The host-based mechanism of RP7214 could allow complementary combinations with direct acting anti-viral drugs, while the broad anti-inflammatory action could potentially mitigate the cytokine mediated inflammatory symptoms typically seen in SARS-CoV-2 & other viral infections.
Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said “There is an exceptional need for oral antiviral drugs that are suitable for Covid-19 treatment across all hospital and out-patient settings. We are pleased to advance RP7214 into a Phase 1 clinical trial for the treatment of Covid-19 under a US FDA IND. RP7214 has a unique preclinical profile, high oral bioavailability, robust anti-viral potency and broad anti-inflammatory role, that we expect will translate in the clinic and support its eventual development as a potential treatment for Covid-19 ”.
About Rhizen Pharmaceuticals S.A.:
Rhizen Pharmaceuticals is an innovative, clinical-stage biopharmaceutical company focused on the discovery and development of novel onco-therapeutics. Since its establishment in 2008, Rhizen has created a diverse pipeline of proprietary drug candidates targeting several cancers and immune associated cellular pathways. Rhizen is headquartered in La-Chaux-de-Fonds, Switzerland. For additional information, please visit www.rhizen.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201201005815/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Selected as Strategic Reservoir Partner for the Havstjerne Carbon Storage Project25.8.2026 14:46:00 CEST | Press release
Integrated engineering work will support development of the large-scale carbon storage project ahead of a final investment decision Global energy technology company SLB (NYSE: SLB) today announced it has been selected as strategic reservoir partner for the Havstjerne carbon storage project in the Norwegian North Sea, providing technology and engineering services for the concept and front-end engineering and design (FEED) phases. The Havstjerne project is a large-scale offshore carbon storage development in Norway intended to serve industrial emitters across Europe, operated by Harbour Energy (LSE: HBR) in consortium with Stella Maris CCS, a Yinson Production company. SLB will coordinate an integrated project scope that connects analysis of the underground storage reservoir with injection well design, subsea infrastructure and plans for monitoring stored CO2 as the Havstjerne partnership develops the project’s technical, cost and schedule basis ahead of a final investment decision. The
Moody’s Brings Its Decision-Grade Intelligence to Gemini Enterprise for Financial Services25.8.2026 14:05:00 CEST | Press release
Integration through Moody’s Credit MCP server brings trusted credit ratings, research, and entity intelligence into Google Cloud’s new industry-specific AI solution for financial services Moody’s Corporation (NYSE: MCO) today announced that its connected intelligence is now available in Google Cloud’s Gemini Enterprise for Financial Services through the Moody’s Credit Model Context Protocol (MCP) server. As a launch partner for Google Cloud’s Gemini Enterprise for Financial Services, Moody’s gives financial professionals working in the platform direct access to credit ratings and research from Moody’s Ratings, along with Moody’s curated intelligence on companies, entities, and risk. “Delivering decision-grade intelligence wherever financial professionals work is how we help our customers stay ahead as agentic AI reshapes financial workflows,” said Ana Meauta, Managing Director, Channel Sales Partnerships at Moody’s. “With Gemini Enterprise for Financial Services, our customers can acce
Born in Riyadh. Sold Out in Paris. stc and EWC a Winning Partnership.25.8.2026 13:02:00 CEST | Press release
stc group was the Founding and Elite Partner of the Esports World Cup for the third consecutive year. EWC 2026, the largest edition of the tournament to date, brought together more than 2,000 players and 200 clubs from over 100 countries, competing across 25 tournaments and 24 game titles. stc group, a leading digital enabler, concluded its third consecutive year as a Founding and Elite Partner of the Esports World Cup (EWC), supporting the tournament as it staged its first edition outside Saudi Arabia in Paris. The largest EWC to date brought together more than 2,000 professional players and 200 clubs from over 100 countries, competing across 25 tournaments and 24 game titles for a prize pool exceeding $75 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825372468/en/ Fans hold up the stc/EWC banner during the Esports World Cup 2026 grand final at the Accor Arena in Paris (Photo: AETOSWire) The move to Paris marke
Ansaldo Energia Selects Kinaxis to Power the Future of Global Energy Infrastructure25.8.2026 13:00:00 CEST | Press release
One of Italy's most historic industrial companies invests in AI-powered Maestro™ platform as demand for power generation technology accelerates worldwide Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, today announced that Ansaldo Energia, a global leader of power generation technology, has selected the Kinaxis Maestro™ platform to help orchestrate its complex supply chain in supporting one of the fastest-growing infrastructure markets in the world. For more than 170 years, Ansaldo Energia has stood at the heart of Italy's industrial heritage, helping shape the nation's energy future while becoming a global leader in power generation technology. Today, as demand for reliable energy infrastructure accelerates, driven by AI, hyperscale data centers, electrification and energy security, Ansaldo Energia is navigating increasingly complex, high-value manufacturing programs, extended production cycles and a rapidly evolving supply chain. The se
UL Solutions Expands Capabilities in Italy to Create European Retail Center of Excellence Supporting Customers From Product Concept to Market25.8.2026 13:00:00 CEST | Press release
Building on 40 years of technical expertise in Italy, UL Solutions has created a European Retail Center of Excellence with an enhanced portfolio of services. UL Solutions has expanded capabilities at its Northern Italy site to create a European Retail Center of Excellence, a regional safety and performance services hub for retailers, brands and manufacturers. The Center now offers pre-market services to support retail product development, supplier selection and raw materials sourcing. Combining upstream support, life cycle management, regulatory insight and sustainability expertise, the site helps customers bring products to market safely and efficiently. UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has expanded capabilities at its site in Lombardy, Italy, to create the European Retail Center of Excellence, giving retailers, brands and manufacturers access to a broader portfolio of services designed for a technology-enabled and rapidly in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom